New Cancer Vaccine Implant from Harvard Reprograms Our Cells
In brief: An implantable cancer vaccine from Harvard has already shown promising results in mice, and researchers are testing it in a clinical trial on humans. [This article first appeared on LongevityFacts. Author: Brady Hartman. ] An implantable cancer vaccine being tested on patients by Harvard’s Wyss Institute is a new type of immunotherapy that holds promise to treat a wide range of cancers … Continue reading New Cancer Vaccine Implant from Harvard Reprograms Our Cells
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed